Skip to main content

SkinHealth Systems Inc.

corporate_fare Company Profile

SkinHealth Systems Inc.

SKIN·NASDAQ·Industrial Applications And Services·CIK 0001818093

The Beauty Health Company is a global medical aesthetics company that provides clinically proven solutions for skin health and supports healthcare providers. The company's core offering is Hydrafacial, a professional skincare treatment, complemented by SkinStylus microneedling and HydraScalp powered by Keravive. The Beauty Health Company integrates advanced device technology, proprietary consumable products, and clinical validation to deliver treatments through a worldwide network of providers. Hydrafacial is the company's primary brand and created the hydradermabrasion category. It uses a patented delivery system to cleanse, extract, and hydrate the skin with proprietary solutions and serums. The HydraScalp powered by Keravive treatment, an extension of Hydrafacial, cleanses, exfoliates, and hydrates the scalp and hair follicles to support natural hair growth and improve the appearance of healthier, thicker, fuller-looking hair. SkinStylus specializes in nano-channeling and microneedling products, offering non-invasive or minimally-invasive skin treatments. The main Hydrafacial product is the Syndeo device, which is the current generation of its delivery system, along with its associated serum solutions and consumables. The Syndeo device is classified as a Class I exempt medical device by the U.S. Food and Drug Administration (FDA). Syndeo features updated hardware and software, including Wi-Fi connectivity and radio frequency identification, which enable data collection to personalize skincare experiences. Predecessor models of the Hydrafacial delivery system include the Elite Tower and the Allegro.

SkinHealth Systems Inc. (NASDAQ:SKIN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for SKIN at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Beauty Health Reports Narrowed Net Loss, Improved Margins, and Proactive Debt Management in Full-Year 2025
  • Beauty Health Reports Improved Profitability in Q4 & FY25 Despite Sales Decline; Issues Cautious 2026 Outlook
  • Beauty Health Co Settles Derivative Lawsuit, Implements Major Governance Reforms

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$300.79M
Net Income
-$9.52M
Diluted EPS
-$0.16
Op. Cash Flow
$37.48M
Free Cash Flow
$37.18M
Gross Profit
$196.36M
Operating Income
-$20.8M
Cash & Equivalents
$232.67M
Total Debt
$240.43M
Debt / Equity
3.94×
Net Margin
-3.2%
Shares Outstanding
127.52M sh
Source: 10-K · filed 2026-03-12 · accession 0001628280-26-017376
$11.77
52-week range · as of 2026-11-05 $9.68 – $34.8
Market cap
$77M
Volume
88.5K (1.2× avg)
3-mo avg 73.4K
Live data · 2026-11-22 06:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SKIN - Filings & News (Page 2)

SKIN
Mar 12, 2026, 5:24 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info
SKIN
Mar 12, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info
SKIN
Mar 06, 2026, 4:32 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $11.77 info
Change: Reverse Stock Split info
Market Cap: $77.005M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets